ABSTRACT
T
he International Subarachnoid Aneurysm Trial demonstrated that patients with aneurysmal SAH treated with endovascular coiling had a significantly decreased absolute risk of death or dependency at 1 year compared with patients undergoing surgical clipping. 1 Because ISAT only randomized patients who were suitable for both coil and clip therapy, just 22% of patients screened, 2 the generalizability of these results has been questioned. 3 Despite this ongoing criticism, subsequent reports indicate that there is a trend toward an increased use of coiling over clipping for patients with aneurysmal SAH. [4] [5] [6] [7] [8] While such a trend toward coiling is undoubtedly occurring, the population of patients treated for SAH is diverse and subgroups of patients within that population will tend to be treated differently, depending on factors such as condition at presentation, aneurysm location, and patient age.
The risk of poor outcome after aneurysmal SAH increases with advancing age, 9 and a less invasive treatment with endovascular coil embolization rather than clipping has been advocated in the elderly. [9] [10] [11] [12] [13] [14] [15] Although the potential benefits of a less invasive treatment in elderly patients with aneurysmal SAH may seem intuitive, 16 some series have shown that the risks of endovascular coil embolization in this age group are not negligible, 17 and 1 singlecenter study demonstrated that the introduction of coil embolization of ruptured aneurysms was not associated with improved outcomes in elderly patients. 16 However, these studies were limited by the relatively small number of patients available for analysis. To examine the application of this approach in practice in the United States and the effect that this might have on outcomes, we applied the Nationwide Inpatient Sample data from 2001 to 2009 to determine trends with time in treatment technique choice and outcomes across age groups. 18 We selected all patients with a diagnosis of subarachnoid hemorrhage (Code 430 in the International Classification of Diseases, Ninth Revision, Clinical Modification [ICD-9-CM]) and an ICD-9-CM procedure code of "clipping of aneurysm" (ICD-9-CM code 39.51) or of "coiling of aneurysm," which included "other repair of aneurysm" (ICD-9-CM code 39.52), "endovascular repair or occlusion of head and neck vessels" (ICD-9-CM code 39.72), and "other endovascular repair (of aneurysm) of other vessels" (ICD-9-CM code 39.79). We stratified patients into 4 age groups: 1) patients younger than 50 years of age, 2) patients 50 -64 years of age, 3) patients 65-79 years of age, and 4) patients 80 years or older. For each patient, the Charlson Comorbidity Index was calculated to determine the burden of comorbid diseases. 19 The CCI is predictive of 10-year mortality and is a composite score based on patient comorbidities such as malignancy, cardiovascular disease, respiratory disease, and so forth. Each diagnosis is assigned a score of 1, 2, 3, or 6, depending on how predictive each condition is of mortality. Data such as subarachnoid hemorrhage severity are not included in the CCI. A modified CCI was not applied in this study. The 2 primary end points of this study were discharge status and in-hospital mortality. For each treatment technique, we as- 
MATERIALS AND METHODS

Statistical Analysis
Means are presented with their corresponding SDs. 2 For each year, increasing age was associated with an increased proportion of patients undergoing endovascular coiling (Fig 1) .
Outcomes for 2001-2009 are summarized in Table 1 . For clipped patients, increasing age predicted a decreased proportion of patients being discharged home and an increased proportion of patients being discharged to long-term facilities or suffering inhospital mortality. The mean length of stay increased significantly with increasing age group as did the non-age-corrected Charlson Comorbidity Index. The same was true for patients undergoing endovascular coiling.
When comparing outcomes for all patients (treated with either clipping or coiling), we found significant differences between the 2 time periods. These data are summarized in When performing multivariate logistic regression analysis (Table 2) , we found that for both clipped and coiled patients, increasing age and increasing CCI were predictive of increased mortality. 
DISCUSSION
Our study demonstrates that between 2001 and 2009, there has been a substantial increase in the proportion of patients with ruptured aneurysms undergoing endovascular coiling. This increase is more prominent among older patients. The relative strengths and weaknesses of clipping and coiling have been shifting with time, and treating physicians incorporate their understanding of the state-of-the-art for these procedures into their clinical decision-making process. It seems that despite public debate and controversy over the results of the ISAT trial, 20, 21 patients are increasingly being referred for endovascular therapy. However, while coiling has become the procedure of choice for most patients, clipping is still being offered to a substantial number of patients, especially those who are younger. The lower use of coiling in younger patients is supported by the ISAT results, which showed little difference in outcomes for clipping and coiling for patients 40 years old and younger, 22 and by the better durability of surgical clipping.
The NIS data base is quite different from a randomized study. It includes all patients treated with clipping and coiling and is, therefore, affected by biases related to choice of treatment. It is not possible to know, from the NIS, the condition of patients at presentation, but it is quite likely that patients in worse clinical condition tended to be directed toward endovascular therapy. The distribution of aneurysm location would be expected to be quite different in the clipping and coiling groups (eg, more basilar aneurysms in the coiling group and more middle cerebral artery aneurysms in the clipping group). Also, the less invasive nature of coiling relative to clipping has resulted in aneurysm treatment for patients of poor clinical grade who would not have been offered 6 This Canadian study was performed at an earlier stage in the development of endovascular therapy, which perhaps helps explain the worse outcomes with coiling. It is quite possible that, especially at the beginning of coil use, primarily patients considered to be poor candidates for surgery were treated with coil embolization.
Other studies have suggested that incorporation of the ISAT results into practice has improved the outcome of aneurysmal SAH. Qureshi et al 5 showed that the in-hospital mortality in the United States after admission for spontaneous subarachnoid hemorrhage decreased from 27% to 24% (P ϭ .003) as the fraction of coiled-versus-clipped cases increased from 8% to 43% in the 3 years after the publication of the ISAT relative to the 3 years prior. Following publication of the ISAT study, concerns existed about the generalizability of the outcome observed in the study to the United States, where there is a higher degree of subspecialization among neurosurgeons involved in the care of patients with aneurysmal SAH. The Barrow Ruptured Aneurysm Trial, a randomized trial of clipping versus coiling, offers perhaps the most compelling confirmatory evidence to support a shift toward endovascular therapy following ISAT. 23 Poor outcome was observed in 33.7% of the patients assigned to clipping and in 23.2% of the patients assigned to coiling (odds ratio, 1.68; 95% CI, 1.08 -2.61; P ϭ .02). If BRAT patients who entered the study with a Hunt and Hess grade of I or II are considered separately, poor outcomes were associated with 9.4% of patients treated with endovascular therapy and 19.8% of patients treated with surgical clipping.. A policy of intent-to-treat favoring coil embolization resulted in fewer poor outcomes than clip occlusion at 1 year following treatment. Although most aneurysms assigned to the coil treatment group in BRAT were treated by coil embolization, a substantial number crossed over to surgical clipping; this finding indicates that surgery is still an important therapeutic option in many patients. 23 The durability of coil embolization is a concern because the ISAT study has demonstrated a small but real risk of delayed rupture of the target aneurysm, and this risk is higher with coiling than with surgical clipping. However, this small risk of delayed rupture (approximately 0.3%/year) did not negate the benefit seen after coiling during the first year. 24 It is possible that the durability of coiled aneurysms may have improved with better technology, increased operator experience, and better judgment of which aneurysms to treat. In BRAT, no delayed ruptures were reported in the endovascular arm after 2 years. 23 Outcomes for patients treated with clipping during 2001-2004 were quite similar to those of patients treated with coiling during 2005-2009, suggesting that there were no major changes in practice that improved outcomes from clipping for patients age 65 years and older. However, mortality among coiled patients 65 of age and older declined between the 2 time periods. A decrease in mortality in patients treated with endovascular therapy might be due to improvements in techniques but likely reflects the increasing use of endovascular therapy in patients with less severe presentations during the latter period. Because the NIS does not allow determination of a patient's condition at presentation, we cannot confirm this with certainty.
Our results show only 15% of patients 80 years and older and 29% of patients age 65-79 years who underwent clipping or coiling from 2005 to 2009 following a subarachnoid hemorrhage were discharged to home or a short-term care facility. There are many other reports of outcomes for elderly patients with ruptured aneurysms reported in the literature, but the discharge status in the NIS is not precisely comparable with those other studies, which typically report the Glasgow Outcome Scale or the modified Rankin Scale. In the International Cooperative Study on the Timing of Aneurysm Surgery conducted between 1980 and 1983, 45% of patients 70 years or older who were surgically treated were independent on the basis of the Glasgow Outcome Scale at 6 months. 25 Results from a multicenter North American study conducted from 1989 to 1991 (ie, also before coiling was a treatment option) showed that 37% of those 70 years and older were independent at 3 months on the basis of the Glasgow Outcome Scale, and outcome was highly dependent on condition at presentation. 26 The outcomes in single-center series were highly dependent on condition at presentation, with Hunt and Hess grades 1 and 2 leading to good outcomes in 57%-94%, and Hunt and Hess grades 4 and 5 leading to favorable outcome in 0%-16%. [9] [10] [11] [12] [13] 15 It is impossible to know the condition at presentation of the patients in the NIS, but it is quite likely that many of the bad outcomes in the NIS patients were due to the severity of the initial hemorrhage. A subgroup analysis of patients 65 years and older enrolled in ISAT showed that 60.1% of patients allocated to coiling were independent compared with 56% allocated to clipping (P ϭ .47). 17 These outcomes are significantly better than those in the NIS, probably because 83% of the patients in ISAT were World Federation of Neurosurgical Societies grade 1 or 2. 17 In patients with internal carotid artery or posterior communicating artery aneurysms, 72% of patients undergoing endovascular therapy were independent compared with only 52% undergoing clipping (P Ͻ .05). However, the reverse was true for middle cerebral artery aneurysms, with good outcome occurring in 46% of patients treated with coiling and in 87% of patients treated with clipping (P Ͻ .05). This demonstrates that in addition to age, aneurysm location is a critical factor to consider in the choice of therapy. An overly aggressive approach to coil embolization could result in a higher complication rate that might offset the benefits of endovascular therapy demonstrated in ISAT and BRAT. It therefore remains important that high-quality surgical clipping be available as a treatment technique for ruptured cerebral aneurysms. Ideally, ruptured intracranial aneurysms should be treated in large-volume centers with extensive expertise in both open surgical and endovascular techniques and where treatment decisions are made by consensus after careful evaluation of each case. 27 The proportions of ruptured aneurysms treated with coiling versus clipping for all age groups with time appear to have reached a plateau, indicating that a relative equilibrium was reached. This equilibrium between clipping and coiling will vary somewhat from center to center depending on local expertise and patient referral patterns. As we learn more in the future about the relative strengths of clipping and coiling for specific patients and specific aneurysms, the balance may shift again. In addition to the limitations already mentioned, coding inaccuracies can affect the accuracy of any administrative data base. This data base does not offer any data on the severity of SAH on presentation and aneurysm geometric features (aspect and dometo-neck ratio), size, or location. We were unable to assess the effects of improved neurocritical care on outcomes for patients in this study. Information on long-term outcomes is not available from the NIS, and it is well-known that patients with aneurysmal subarachnoid hemorrhage can improve considerably after discharge. We do not have information on recurrent bleeding. How- ever, the experiences of ISAT, 24 the Cerebral Aneurysm Rerupture After Treatment 28 study, and the BRAT study suggest that it is quite unlikely that the initial treatment benefit of endovascular coil embolization could be overwhelmed by delayed hemorrhages or complications related to retreatment.
CONCLUSIONS
Between 2001 and 2009, there has been a significant increase in the proportion of patients with ruptured aneurysm undergoing endovascular coiling, which was more pronounced in older patients. Mortality from aneurysmal subarachnoid hemorrhage decreased during the past decade, regardless of aneurysm treatment technique.
